DDO Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of DDO Antibodies for investigating D-amino acid oxidase (DDO) in various biological processes. DDO Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). D-amino acid oxidase is an enzyme that plays a crucial role in the metabolism of D-amino acids, which are important for neurotransmission and the regulation of various physiological functions. The activity of DDO has been implicated in neurodegenerative diseases and psychiatric disorders, making it a significant target for research. Understanding the function and regulation of DDO can provide insights into potential therapeutic strategies for these conditions. DDO monoclonal antibodies enable precise detection and analysis of D-amino acid oxidase expression patterns across different tissues and experimental conditions. Researchers can utilize DDO monoclonal antibodies to explore cellular localization, protein interactions, and enzymatic activity in various model systems. Santa Cruz Biotechnology monoclonal antibodies for DDO support cutting-edge research that advances our understanding of neurodegenerative diseases and psychiatric disorders.